Get the Stockscreener App
71.52
3.50%
2.42
Caredx Inc stock is traded at $71.52, with a volume of 350.28K.
It is up +3.50% in the last 24 hours and up +12.31% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$69.10
Open:
$69.1
24h Volume:
350.28K
Relative Volume:
0.29
Market Cap:
$3.70B
Revenue:
$412.82M
Net Income/Loss:
$-8.19M
P/E Ratio:
-464.11
EPS:
-0.1541
Net Cash Flow:
$64.17M
1W Performance:
+3.35%
1M Performance:
+12.31%
6M Performance:
+227.32%
1Y Performance:
+392.90%
1-Day Range:
$68.60
$71.69
1-Week Range:
$66.84
$72.71
52-Week Range:
$14.22
$72.71
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, NTRA, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
71.52 | 3.70B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
695.80 | 257.27B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
232.26 | 163.28B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
412.74 | 59.49B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
178.06 | 50.20B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
464.06 | 45.59B | 3.77B | 449.25M | 240.68M | 7.8556 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-02-26 | Initiated | Canaccord Genuity | Buy |
| Aug-03-26 | Upgrade | Craig Hallum | Hold → Buy |
| Jan-06-26 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
CareDx to Report Q3 Earnings: Transplant Testing Growth in Focus - Zacks Investment Research
CareDx Reports AlloSure Kidney Data Showing Nearly Threefold Higher Risk of Adverse Transplant Outcomes - citybiz
CareDx links AlloSure Kidney to adverse graft outcomes - Mugglehead Investment Magazine
CareDx presents kidney transplant monitoring study results By Investing.com - Investing.com Australia
CareDx data links AlloSure Kidney test to graft outcome risk - StreetInsider
CareDx Announces New KOAR Data Linking Elevated AlloSure® Kidney to Nearly 3-Fold Higher Risk of Adverse Graft Outcomes in Patients with Borderline Rejection or TCMR at ASN Kidney Week 2026 - Business Wire
CareDx Faces First NavDx Quarter With Street Estimates Trailing Its Raised Outlook - Finviz
Caredx Inc stock hits 52-week high at 72.61 USD By Investing.com - Investing.com Canada
Pretax income of CareDx, Inc. – HAM:1K9 - TradingView
CareDx Inc (CDNA) Shares Surge 4.8% -- What GF Score of 64 Tells Investors - GuruFocus
CareDx Price Target Raised to $80.00/Share From $65.00 by Canaccord Genuity - Moomoo
CDNA Maintained by Canaccord Genuity -- Price Target Raised to $80 - GuruFocus
CareDx Inc (CDNA) Shares Fall 4.0% -- GF Value Says Still Overva - GuruFocus
CareDx, Inc. (CDNA) stock price, news, quote and history - Yahoo Finance Australia
CareDx, Inc (1K9.SG) stock price, news, quote and history - Yahoo Finance Australia
CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026 - Business Wire
CareDx Inc (CDNA) Stock Up 3.7% but GF Value Says Overvalued -- GF Score: 64/100 - GuruFocus
CareDx (NASDAQ:CDNA) Stands Out for High Growth and Improving Fundamentals - ChartMill
Form 4 Caredx Inc For: 11 October By Investing.com - Investing.com South Africa
Form 4 Caredx Inc For: 11 October By Investing.com - Investing.com India
CareDx (CDNA) Stock Gets Fair Value Bump After Reimbursement And Analyst Target Changes - Yahoo Finance
A Look at CareDx Inc (CDNA) After 4.0% Gain -- GF Value $25.50 v - GuruFocus
Form 4 Caredx Inc For: 5 October By Investing.com - Investing.com South Africa
CareDx General Counsel Reports Withholding of Shares for RSU Tax Obligations - Kalkine Media
CareDx CEO John Walter Withholds 8,511 Shares for Tax on RSU Vesting - Kalkine Media
Stock vesting triggers 997-share tax withholding for CareDx (CDNA) counsel Jeffrey Adam Novack. - Stock Titan
CareDx CCO Jessica Meng Withholds 2,619 Shares for RSU Tax on October 1, 2026 - Kalkine Media
After 8,511 shares were withheld for taxes, CareDx (CDNA) CEO holds 644,937 shares directly. - Stock Titan
Tax withholding leaves CareDx (CDNA) CFO Keith Kennedy with 208,686 directly held shares. - Stock Titan
For stock-vesting taxes, CareDx (CDNA) withholds 2,619 shares from its chief commercial officer. - Stock Titan
A 588-share grant replaces cash pay for CareDx (CDNA) director Michael Goldberg. - Stock Titan
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.
Biotech Stocks At 52-Week HighsCDNA, RCEL, AZTA, HNGE - RTTNews
CareDx, Inc (CDNA) stock price, news, quote and history - Yahoo Finance UK
Caredx Inc stock hits 52-week high at 65.53 USD - Investing.com
Caredx Inc stock hits 52-week high at 65.53 USD By Investing.com - Investing.com Canada
Caredx Inc stock hits 52-week high at 65.53 USD By Investing.com - Investing.com UK
Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks - Zacks Investment Research
Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks - es.tradingview.com
CareDx, Inc. (CDNA) Stock Price, News, Quote & History - Yahoo! Finance Canada
CareDx Refocused On Transplant Testing, And Wall Street Noticed - Finimize
CareDx, Inc. (CDNA) stock price, news, quote and history - Yahoo Finance Singapore
CareDx: I Was Wrong, But The Rally Has Outrun The Fundamentals (Rating Upgrade) - Seeking Alpha
CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar? - Yahoo Finance
CareDx Inc (CDNA) Stock Up 13.0% but GF Value Says Overvalued -- GF Score: 66/100 - gurufocus.com
CareDx +14% on Fresh $74 Analyst Price Target - Yahoo Finance
BTIG raises CareDx stock price target to $74 on transplant outlook - Investing.com
Zacks.com featured highlights include CareDx, Ciena, Celestica, Materion and MACOM Technology Solutions - Yahoo Finance
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently - Benzinga
A Look at CareDx Inc (CDNA) After 4.0% Gain -- GF Value $25.41 v - gurufocus.com
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Caredx Inc Stock (CDNA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| PETER MAAG | Director |
Aug 14 '26 |
Proposed Sale |
45.30 |
7,000 |
317,113 |
0 |
| PETER MAAG | Director |
Aug 13 '26 |
Proposed Sale |
47.07 |
7,000 |
329,505 |
0 |
| PETER MAAG | Director |
Aug 12 '26 |
Proposed Sale |
46.89 |
7,000 |
328,238 |
0 |
| PETER MAAG | Director |
Aug 11 '26 |
Proposed Sale |
47.69 |
7,000 |
333,851 |
0 |
| PETER MAAG | Director |
Aug 10 '26 |
Proposed Sale |
47.66 |
6,902 |
328,949 |
0 |
| ARTHUR TORRES | Director |
Aug 10 '26 |
Proposed Sale |
47.73 |
4,200 |
200,475 |
0 |
| PETER MAAG | Director |
Aug 07 '26 |
Proposed Sale |
45.83 |
27,332 |
1,252,492 |
0 |
| GEORGE W BICKERSTAFF | Director |
Aug 05 '26 |
Proposed Sale |
46.28 |
20,000 |
925,700 |
0 |
| Bickerstaff George | Director |
Aug 05 '26 |
Sale |
46.28 |
20,000 |
925,700 |
134,061 |
| Novack Jeffrey Adam | Secretary and General Counsel |
Aug 05 '26 |
Sale |
46.26 |
2,688 |
124,349 |
106,075 |
6.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):